Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement
Phase 2 Terminated
3 enrolled 11 charts
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Terminated
14 enrolled 10 charts
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Phase 2 Terminated
1 enrolled 1 chart
ALERT-lung
Phase 2 Terminated
14 enrolled 14 charts
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase 2 Terminated
6 enrolled 12 charts
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
Phase 3 Terminated
4 enrolled 5 charts
NIMBLe
Phase 2 Terminated
4 enrolled 4 charts
Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab
Phase NA Terminated
1 enrolled 1 chart
Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
Phase 2 Terminated
9 enrolled 8 charts
Observation or Radical Treatment in Patients With Prostate Cancer
Phase NA Terminated
180 enrolled 9 charts
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Phase 3 Terminated
406 enrolled 14 charts
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Phase 2 Terminated
59 enrolled 8 charts
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase 2 Terminated
26 enrolled 11 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Phase 2 Terminated
6 enrolled 9 charts
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Phase 2 Terminated
2 enrolled 8 charts
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
Phase 3 Terminated
859 enrolled 8 charts
Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
Phase 2 Terminated
6 enrolled 7 charts
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Phase 2 Terminated
4 enrolled 4 charts
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Phase 2 Terminated
31 enrolled 10 charts
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Phase 2 Terminated
3 enrolled 6 charts
S1916 Digital Medicine Program for Pain Control in Cancer Patients
Phase NA Terminated
2 enrolled 5 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Terminated
114 enrolled 8 charts
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
Phase 3 Terminated
269 enrolled 9 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
Phase 2 Terminated
6 enrolled 3 charts
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
Phase 3 Terminated
2 enrolled 5 charts
ROBOPHYSE
Phase NA Terminated
8 enrolled 8 charts
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Phase 1 Terminated
35 enrolled 28 charts
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
Phase 2 Terminated
9 enrolled 5 charts
Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2 Terminated
19 enrolled 4 charts
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
Phase 2/3 Terminated
9 enrolled 5 charts
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Phase 2 Terminated
1 enrolled
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
Phase 2 Terminated
8 enrolled 5 charts
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Terminated
7 enrolled 6 charts
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Phase 2 Terminated
43 enrolled 14 charts
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Phase 2 Terminated
20 enrolled 9 charts
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Phase 1/2 Terminated
17 enrolled 7 charts
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Phase NA Terminated
4 enrolled 5 charts
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase 2 Terminated
23 enrolled 9 charts
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
Phase NA Terminated
102 enrolled 6 charts
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Terminated
521 enrolled 18 charts
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Phase 2 Terminated
65 enrolled 14 charts
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Phase 2/3 Terminated
2 enrolled 8 charts
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Phase 2 Terminated
22 enrolled 9 charts
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Terminated
5 enrolled 3 charts
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Phase 2 Terminated
7 enrolled 9 charts
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 3 Terminated
15 enrolled 5 charts